Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 2/20 | 0.39 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
| ▸ | MMP12 | P39900 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | FABP7 | O15540 | 1/20 | 0.34 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27976432 | 0.98 | CYP19A1 (0.42) | EPHX1CYP19A1CA12CA1CA2 | |
| Hydrazine SCHEMBL3862636 | 0.96 | CYP19A1 (0.42) | EPHX1CYP19A1CA12CA1CA2 | |
| SCHEMBL15995376 | 0.93 | CYP19A1 (0.39) | EPHX1CYP19A1CA12CA1CA2 | |
| Phosphoric Acid SCHEMBL31077872 | 0.90 | CYP19A1 (0.38) | EPHX1CYP19A1CA12CA1CA2 | |
| SCHEMBL398217 | 0.88 | GPR35 (0.34) | EPHX1CYP19A1GPR35 | |
| SCHEMBL28310854 | 0.84 | CYP19A1 (0.39) | EPHX1CYP19A1CA12CA1CA2 | |
| Hydrazine SCHEMBL22505628 | 0.84 | GPR35 (0.33) | CYP19A1GPR35 | |
| SCHEMBL1419796 | 0.84 | EPHX1 (0.40) | EPHX1CYP19A1CA12CA1CA2 | |
| SCHEMBL686006 | 0.83 | CYP19A1 (0.50) | EPHX1CYP19A1CA12CA1CA2 | |
| SCHEMBL20445673 | 0.83 | CYP19A1 (0.46) | EPHX1CYP19A1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9427777-B2 | Process for producing charge retention medium | ASAHI GLASS COMPANY, LIMITED (JP) | 2016-08-30 | — | — | US | claimed |
| CN-1898234-A | Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases | INCYTE CORP (US) | 2007-01-17 | — | — | CN | claimed |
| CN-1045084-C | Novel compound with platelet aggregation inhibitor activity | MEJI SEIKA KABUSHIKI KAISHA (JP) | 1999-09-15 | — | — | CN | claimed |
| CN-1107277-A | Novel compound having platelet aggregation inhibiting effect | MEIJI SEIKA CO (JP) | 1995-08-23 | — | — | CN | claimed |
| US-20240218021-A1 | CYCLIN INHIBITORS | CIRCLE PHARMA, INC. | 2024-07-04 | — | — | US | disclosed |
| US-11999688-B2 | Method for producing dicarboxylic acid | DALIAN INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES (CN) | 2024-06-04 | — | — | US | disclosed |
| WO-2021104486-A1 | COMPOUND CONTAINING BENZENE RING AND APPLICATION THEREOF | 武汉朗来科技发展有限公司 | 2021-06-03 | — | — | WO | disclosed |
| US-20210147331-A1 | METHOD FOR PRODUCING DICARBOXYLIC ACID | DALIAN INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES (CN) | 2021-05-20 | — | — | US | disclosed |
| CN-110615736-B | Preparation method of dicarboxylic acid | 中国科学院大连化学物理研究所 | 2021-01-26 | — | — | CN | disclosed |
| CN-110615736-A | Preparation method of dicarboxylic acid | 中国科学院大连化学物理研究所 | 2019-12-27 | — | — | CN | disclosed |
| WO-2019242038-A1 | METHOD FOR PREPARING DICARBOXYLIC ACID | 中国科学院大连化学物理研究所 | 2019-12-26 | — | — | WO | disclosed |
| CN-104364246-B | Piperidine derivatives useful as GPR119 agonists | 株式会社钟根堂 | 2018-05-22 | — | — | CN | disclosed |
| EP-1710223-A1 | PROCESS FOR PRODUCING ALDEHYDE COMPOUND OR KETONE COMPOUND WITH USE OF MICROREACTOR | Ube Industries, Ltd. (JP) | 2006-10-11 | — | — | EP | disclosed |
| US-5786505-A | TREATING HYDROCARBON IN ACID SOLUTION WITH OXYGEN COMPOUND AND REACTANT METAL ION REDUCING AGENT | BATTELLE MEMORIAL INSTITUTE (US) | 1998-07-28 | — | — | US | disclosed |
| WO-1998008784-A2 | METHOD OF PHOTOCATALYTIC CONVERSION OF C-H ORGANICS | BATTELLE MEMORIAL INSTITUTE (US) | 1998-03-05 | — | — | WO | disclosed |
| US-5708246-A | TO ESTERS | BATTELLE MEMORIAL INSTITUTE (US) | 1998-01-13 | — | — | US | disclosed |
| US-5585515-A | REDOX SYSTEM PRODUCING AN ALCOHOL | BATTELLE MEMORIAL INSTITUTE (US) | 1996-12-17 | — | — | US | disclosed |
| EP-0581845-A1 | METHOD AND REACTION PATHWAY FOR SELECTIVELY OXIDIZING ORGANIC COMPOUNDS | BATTELLE MEMORIAL INSTITUTE (US) | 1994-02-09 | — | — | EP | disclosed |
| WO-1992017425-A1 | METHOD AND REACTION PATHWAY FOR SELECTIVELY OXIDIZING ORGANIC COMPOUNDS | BATTELLE MEMORIAL INSTITUTE (US) | 1992-10-15 | — | — | WO | disclosed |
| US-4761506-A | CATALYTIC HYDROGENATION OF ESTERS OF PERFLUORACETIC ACID ESTERS | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1988-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210147331-A1 | METHOD FOR PRODUCING DICARBOXYLIC ACID | MCCC2, PCCA, PC | EPHX1 2682/4885CYP19A1 201/4885CA12 500/4885 |
| US-20240218021-A1 | CYCLIN INHIBITORS | CCNI, CCNC, CDK2 | EPHX1 2798/4885CYP19A1 165/4885CA12 3760/4885 |
| US-11999688-B2 | Method for producing dicarboxylic acid | MCCC2, PCCA, PC | EPHX1 2682/4885CYP19A1 201/4885CA12 500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.